Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibody humanization predicted by computer graphic analysis

K Ramnarayan1, E Skaletsky

  • 1ImmunoPharmaceutics, Inc., San Diego, CA, USA.

American Biotechnology Laboratory
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standard setting of objective structured practical examination by modified Angoff method: A pilot study.

The National medical journal of India·2016
Same author

Short-term outcomes of a program developed to inculcate research essentials in undergraduate medical students.

Journal of postgraduate medicine·2015
Same author

Avenues for professional development: faculty perspectives from an Indian medical school.

Kathmandu University medical journal (KUMJ)·2013
Same author

Women having abortion in urban Nepal: 2005 and 2010 compared.

Kathmandu University medical journal (KUMJ)·2013
Same author

Fostering research skills in undergraduate medical students through mentored students projects: example from an Indian medical school.

Kathmandu University medical journal (KUMJ)·2012
Same author

Effect of imatinib on the biochemical parameters of the reproductive function in male Swiss albino mice.

Indian journal of pharmacology·2011
Same journal

Experimental strategies enabled by C-terminal protein sequence analysis.

American biotechnology laboratory·1996
Same journal

Affinity chromatography: production and regulatory considerations.

American biotechnology laboratory·1996
Same journal

Cytotoxicity quantification with a cell counter and analyzer system.

American biotechnology laboratory·1996
Same journal

Automated peptide mapping using a multidimensional chromatography workstation.

American biotechnology laboratory·1996
Same journal

Vitamin analysis using capillary zone electrophoresis.

American biotechnology laboratory·1996
Same journal

HPCE separation of protected amino acids and peptides.

American biotechnology laboratory·1996
See all related articles

Clinical trials are refining humanized antibodies, with future focus on antibody fragments and phage library selection. Structural analysis aids in antibody humanization and development of small molecule therapeutics.

Area of Science:

  • Biotechnology
  • Immunology
  • Drug Discovery

Background:

  • Humanized antibodies are crucial in modern therapeutics.
  • Ongoing clinical trials provide essential data for antibody engineering.
  • Advancements in antibody technology are rapidly evolving.

Purpose of the Study:

  • To summarize the current state and future directions of humanized antibody development.
  • To highlight the role of structural biology and computational methods in antibody design.
  • To explore alternative antibody formats and selection strategies.

Main Methods:

  • Review of ongoing clinical trial data for humanized antibodies.
  • Analysis of emerging trends in antibody fragment utilization.
  • Application of computer graphic analysis and molecular modeling for antibody structure prediction.

Related Experiment Videos

  • Investigation of phage display libraries for human antibody specificity selection.

    • Main Results:

    • Clinical trials are continuously informing the next generation of humanized antibodies.
    • Increased emphasis on antibody fragments and phage library selection for therapeutic development.
    • Structural insights from molecular modeling are key for antibody humanization.
    • Antigen binding site analysis can guide the development of small molecule drugs.

    Conclusions:

    • Humanized antibody development is an iterative process driven by clinical data.
    • Future antibody therapeutics will likely involve fragments and novel selection methods.
    • Computational and structural biology are indispensable tools for antibody engineering and drug discovery.